Cargando…

The Influence of Endothelial Function and Myocardial Ischemia on Peak Oxygen Consumption in Patients with Coronary Artery Disease

Impaired endothelial function has been shown to limit exercise in coronary artery disease (CAD) patients and has been implicated in myocardial ischemia. However, the association of endothelial function and ischemia on peak exercise oxygen consumption (VO(2)) has not been previously reported. A total...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacon, Simon L., Sherwood, Andrew, Hinderliter, Alan, Plourde, Annik, Pierson, Lee, Blumenthal, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477573/
https://www.ncbi.nlm.nih.gov/pubmed/23097703
http://dx.doi.org/10.1155/2012/274381
Descripción
Sumario:Impaired endothelial function has been shown to limit exercise in coronary artery disease (CAD) patients and has been implicated in myocardial ischemia. However, the association of endothelial function and ischemia on peak exercise oxygen consumption (VO(2)) has not been previously reported. A total of 116 CAD patients underwent standard exercise stress testing, during which VO(2) was measured. On a separate day, endothelial-dependent and -independent function were assessed by ultrasound using flow-mediated arterial vasodilation (FMD) and sublingual glyceryl trinitrate administration (GTNMD) of the brachial artery. Patients with exercise-induced myocardial ischemia had lower FMD than nonischemic patients (3.64 ± 0.57 versus 4.98 ± 0.36, P = .050), but there was no difference in GTNMD (14.11 ± 0.99 versus 15.47 ± 0.63, P = .249). Analyses revealed that both FMD (P = .006) and GTNMD (P = .019) were related to peak VO(2). However, neither the presence of ischemia (P = .860) nor the interaction of ischemia with FMD (P = .382) and GTNMD (P = .151) was related to peak VO(2). These data suggest that poor endothelial function, potentially via impaired NO production and smooth muscle dysfunction, may be an important determinant of exercise capacity in patients with CAD, independent of myocardial ischemia.